gms | German Medical Science

104. Jahrestagung der Deutschen Ophthalmologischen Gesellschaft e. V. (DOG)

21. - 24.09.2006, Berlin

Proliferation of human lens epithelial cells (hLEC) is determined by sustained intracellular calcium level

Meeting Abstract

Suche in Medline nach

  • A. Meissner - University of Rostock, Institute of Physiology, Rostock
  • T. Noack - University of Rostock, Institute of Physiology, Rostock

Deutsche Ophthalmologische Gesellschaft e.V.. 104. Jahrestagung der Deutschen Ophthalmologischen Gesellschaft (DOG). Berlin, 21.-24.09.2006. Düsseldorf, Köln: German Medical Science; 2006. Doc06dogP216

Die elektronische Version dieses Artikels ist vollständig und ist verfügbar unter:

Veröffentlicht: 18. September 2006

© 2006 Meissner et al.
Dieser Artikel ist ein Open Access-Artikel und steht unter den Creative Commons Lizenzbedingungen ( Er darf vervielfältigt, verbreitet und öffentlich zugänglich gemacht werden, vorausgesetzt dass Autor und Quelle genannt werden.




It has been shown, that the T-type calcium channel blocker Mibefradil inhibits proliferation in human lens epithelial cells [1]. T-type und L-type calcium channels are substantially present in hLEC and total calcium currents are inhibited by Mibefradil at concentrations of 1 mM [2]. The anti-proliferative mechanism remains unclear, since other effects than calcium channel blockade might be involved at these concentrations of the drug.


Epithelial cells of the human lens (HLE-B3, ATCC) were investigated with cell culture techniques; cell proliferation was determined by incubating a defined cell number with different concentrations of Mibefradil, Verapamil and other calcium channel modulating drugs over 48 h. Cell number was determined by staining with Trypan blue solution. Western Blot analysis was accomplished under standard conditions, using a-pERK, a-ERK, a-caspase and a-Cav1.2 and a-Cav3.1. Calcium measurements were performed using Fura-2 technique.


Mibefradil inhibited proliferation at 1 mM (IC50), whereas Verapamil in concentrations of 10 mM. The activation of MAPK 3 was reduced by both antagonists in the concentration ranges, in which they inhibited proliferation. Mibefradil also induced activation of caspase-3. Mitogenic HLE-B3 cells reacted more sensitive to a treatment with Mibefradil as to Verapamil possibly caused by a higher expression of T-type Ca-channels. The L-type calcium channel opener, Bay K 8644, had clear proliferative effects on hLECs: during the presence of this drug, the anti-proliferative action of Mibefradil was strongly attenuated.


Caspase-3 activation and MAPK 3 inhibition are linked to a reduction of intracellular calcium level which can be modulated by calcium channel blockade. Moreover, the action of the calcium channel opener Bay K 8644 strongly indicates, that proliferation of hLECs is linked to intracellular sustained calcium levels, which are also sensitive to Mibefradil.

Supported by the DFG No 269/5


Nebe et al. bla. Graefe's Arch Clin Exp Ophthalmol. 2004;242:597-604.
Meissner, Noack. bla. Acta Physiologica. 2006;186:178.